Defective Drug News: 3 Drugs Currently Under Scrutiny

By | Dangerous & Defective Drugs

When it comes to your health, you can never play it too safe. If you’re behind on defective drug news, read on to learn about the three most scrutinized drugs this year. Xarelto – Bayer and Johnson & Johnson This blood thinner is the subject of over 5,000 lawsuits involving 500 patient deaths. The Food and Drug Administration approved the drug after 14,000 patients participated in a three-year clinical trial. The results of that study are now highly suspect since one of the blood-testing devices apparently malfunctioned. Anticoagulants prevent clotting and keep blood flowing to vital organs. Doctors normally prescribe in…

Read More

Defective products roundup

By | Dangerous & Defective Drugs

Product liability and defective products are problems that every manufacturer encounters at one time or another. Unfortunately, these instances commonly cause injury for the average consumer. Numerous products are continually in the headlines when defects are discovered. When an injury occurs as a result of a defective product, a personal injury attorney can help. Airbag Inflators In 2015, a man from lost his life from a defective Takata airbag. While driving his pickup, he was involved in a collision. The airbag deployed. However, the force behind the airbag also propelled a piece of metal, which impaled the man causing a…

Read More

Actos Manufacturer May Have Covered Up Diabetes Drug Side Effects

By | Dangerous & Defective Drugs

A medical reviewer from Takeda Pharmaceutical Company, manufacturer of diabetes drug Actos, is blowing the whistle on her former employer, claiming that it covered up known cases of congestive heart failure related to Actos use. Specifically, she alleges that the company did not consider “non-hospitalized or non-fatal” cases of congestive heart failure between 2007 and 2010 as “serious” and report the side effects to the FDA. The U.S. Food and Drug Administration (FDA) regulates the production of dangerous drugs and requires negative side effects be self-reported to the agency via its Adverse Event Reporting System. The whistleblower claims that Takeda’s…

Read More

Long-term Actos Use Linked to Bladder Cancer

By | Dangerous & Defective Drugs

In June 2011, the Food and Drug Administration (FDA) warned that the use of Actos over an extended period of time may cause bladder cancer. Use of the dangerous & defective drug was discontinued in France and Germany, but not in the United States. The warning followed a 2010 study that revealed an increased likelihood of developing bladder cancer in those who had taken Actos for a year or more. With the warning, Actos joins a growing list of known dangerous & defective drugs once thought to help patients, but later found to harm them. Actos was intended to help people with…

Read More

Acetaminophen (Tylenol) Leading Cause of Liver Failure in the U.S.

By | Dangerous & Defective Drugs

An advisory panel of the Food and Drug Administration (FDA) suggested lowering the recommended and maximum daily doses of acetaminophen to 650 mg and approximately 2,600 mg, respectively. The lowered dosing is intended to protect consumers from unknowing overdose that may lead to liver complications or failure. Acetaminophen-containing drugs, like Percocet and Vicodin, are also on the chopping block. Both drugs are made up of a combination of hydrocodone or oxycodone and acetaminophen. The suspected problem with these types of pain killers is that many who take them are unaware that they also contain acetaminophen and they may take additional Tylenol or…

Read More

Avandia To Be Removed from Tennessee Retail Pharmacies

By | Dangerous & Defective Drugs

Recognizing the heart risks Avandia poses to those who use it, the Food and Drug Administration announced new rules in May to pull the diabetes drug from the shelves of retail pharmacies throughout Tennessee and the rest of the U.S. Although the new rules don’t go into effect until November, many pharmacies have already stopped dispensing the controversial drug. Linked to severe cardiovascular events, including heart attack, congestive heart failure, stroke and liver problems, the FDA has determined that in the majority of cases, the risks of Avandia far outweigh its benefits for those living with Type 2 diabetes. The FDA’s…

Read More

FDA Warns Against Avandia

By | Dangerous & Defective Drugs

Avandia, a popular but controversial diabetes medication, is facing new government scrutiny, putting manufacturer GlaxoSmithKline at risk of potentially costly new lawsuits. In February, the New York Times obtained a confidential Food and Drug Administration report that linked more than 300 deaths to Avandia within a three-month period. The report recommended pulling the drug from the market. The new FDA data follows a U.S. Senate Finance Committee report released in February. The senate report alleges that GSK knew of the health risks prior to 2007 but concealed them. Avandia could quite possibly be a dangerous and defective drug. Avandia first hit…

Read More